Corbus Pharmaceuticals Holdings (CRBP) Asset Utilization Ratio (2015 - 2022)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Asset Utilization Ratio came in at 0.0 in Q2 2022, down 96.18% year-on-year from 0.03 in Q2 2021, and down 52.38% quarter-over-quarter from 0.0 in Q1 2022.
Corbus Pharmaceuticals Holdings (CRBP) Asset Utilization Ratio (2015 - 2022) Analysis & Trends
Corbus Pharmaceuticals Holdings' Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.0 for Q2 2022.
- On a quarterly basis, Asset Utilization Ratio fell 96.18% year-over-year to 0.0 in Q2 2022; TTM through Jun 2022 was 0.0, a 96.18% decrease from a year earlier, with the FY2021 full-year figure at 0.01, down 87.29% from the prior year.
- Asset Utilization Ratio eased to 0.0 in Q2 2022 per CRBP's latest filing, from 0.0 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.44 in Q3 2019 and bottomed at 0.29 in Q2 2020.
- The 5-year median for Asset Utilization Ratio is 0.03 (2018), against an average of 0.04.
- Across the five-year window, Asset Utilization Ratio soared 907.31% in 2019 and plunged 184.23% in 2020, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.06 in 2018, then surged by 48.97% to 0.09 in 2019, then slumped by 40.81% to 0.05 in 2020, then tumbled by 84.63% to 0.01 in 2021, then tumbled by 85.88% to 0.0 in 2022.
- Per Business Quant, the three latest CRBP Asset Utilization Ratio figures stand at 0.0 (Q2 2022), 0.0 (Q1 2022), and 0.01 (Q4 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.03 |
| Mar 31, 2021 | 0.03 |
| Dec 31, 2020 | 0.05 |
| Sep 30, 2020 | -0.26 |
| Jun 30, 2020 | -0.29 |
| Mar 31, 2020 | 0.09 |
| Dec 31, 2019 | 0.09 |
| Sep 30, 2019 | 0.44 |
| Jun 30, 2019 | 0.35 |
| Mar 31, 2019 | 0.05 |
| Dec 31, 2018 | 0.06 |
| Sep 30, 2018 | 0.04 |
| Jun 30, 2018 | 0.04 |
| Mar 31, 2018 | 0.03 |
| Dec 31, 2017 | 0.05 |
| Sep 30, 2017 | 0.08 |